Alain Flinois

663 total citations
25 papers, 467 citations indexed

About

Alain Flinois is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Alain Flinois has authored 25 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Alain Flinois's work include Cancer Treatment and Pharmacology (9 papers), Multiple Myeloma Research and Treatments (7 papers) and HER2/EGFR in Cancer Research (4 papers). Alain Flinois is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Multiple Myeloma Research and Treatments (7 papers) and HER2/EGFR in Cancer Research (4 papers). Alain Flinois collaborates with scholars based in Switzerland, France and United Kingdom. Alain Flinois's co-authors include Sebastian Gonzalez‐McQuire, Kwee Yong, Leah Fink, Paul Schoen, María‐Victoria Mateos, Michèle Cavo, Marc S. Raab, Christoph Driessen, Michel Delforge and Lionel Karlin and has published in prestigious journals such as Blood, Annals of Oncology and British Journal of Haematology.

In The Last Decade

Alain Flinois

21 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Flinois Switzerland 9 365 269 254 54 25 25 467
Kejal Parikh United States 10 446 1.2× 280 1.0× 298 1.2× 113 2.1× 45 1.8× 40 634
Per Trøllund Pedersen Denmark 13 313 0.9× 191 0.7× 251 1.0× 85 1.6× 67 2.7× 28 463
Jagoda Jasielec United States 13 390 1.1× 339 1.3× 252 1.0× 44 0.8× 24 1.0× 40 553
S. Verelst Netherlands 6 261 0.7× 139 0.5× 218 0.9× 46 0.9× 29 1.2× 14 337
Omar Nadeem United States 13 263 0.7× 229 0.9× 260 1.0× 58 1.1× 22 0.9× 79 468
Alessandra Pompa Italy 10 172 0.5× 101 0.4× 91 0.4× 50 0.9× 16 0.6× 23 244
Shakira J. Grant United States 9 151 0.4× 87 0.3× 192 0.8× 38 0.7× 17 0.7× 39 373
Ulf Christian Frølund Denmark 10 247 0.7× 163 0.6× 156 0.6× 75 1.4× 19 0.8× 27 318
Lisa Sproat United States 9 155 0.4× 93 0.3× 82 0.3× 42 0.8× 15 0.6× 18 340
Charlene M. McShane United Kingdom 9 76 0.2× 85 0.3× 67 0.3× 54 1.0× 28 1.1× 27 326

Countries citing papers authored by Alain Flinois

Since Specialization
Citations

This map shows the geographic impact of Alain Flinois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Flinois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Flinois more than expected).

Fields of papers citing papers by Alain Flinois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Flinois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Flinois. The network helps show where Alain Flinois may publish in the future.

Co-authorship network of co-authors of Alain Flinois

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Flinois. A scholar is included among the top collaborators of Alain Flinois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Flinois. Alain Flinois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kafatos, George, et al.. (2020). The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe. Drugs - Real World Outcomes. 7(2). 119–130. 1 indexed citations
2.
Saghatchian, Mahasti, Elsa Curtit, David Coeffic, Alain Flinois, & Christelle Lévy. (2020). Étude en vie réelle de la survie à 7 ans des patientes traitées avec trastuzumab pour un cancer du sein précoce HER2+. Bulletin du Cancer. 107(7-8). 745–755. 1 indexed citations
3.
Kafatos, George, Sabada Dube, Gaston Demonty, et al.. (2020). Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients’ Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology Centers. Clinical Colorectal Cancer. 19(2). 100–108.e9. 8 indexed citations
4.
Raab, Marc S., Leah Fink, Paul Schoen, et al.. (2018). Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016. British Journal of Haematology. 185(5). 981–984. 17 indexed citations
5.
Despiégel, Nicolas, Alain Flinois, Grèce Saba, et al.. (2018). Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France. Clinical Lymphoma Myeloma & Leukemia. 19(1). e13–e28. 38 indexed citations
6.
Colomer, Rámón, et al.. (2017). Real-world treatment in patients with HER2+ metastatic breast cancer. Breast Cancer Research and Treatment. 168(1). 197–205. 8 indexed citations
7.
Gonzalez‐McQuire, Sebastian, Kwee Yong, Henri Leleu, et al.. (2017). Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy. Journal of Medical Economics. 21(5). 450–467. 16 indexed citations
8.
Gonzalez‐McQuire, Sebastian, et al.. (2016). Retrospective Chart Review Study to Evaluate the Cost of Care of Patients with Symptomatic Multiple Myeloma in France. Value in Health. 19(3). A155–A155. 1 indexed citations
9.
Fink, Leah, Justyna Amelio, Mark Harries, et al.. (2016). Making decisions on resectability and injectability status of lesions in the management of advanced melanoma in Germany, France and the UK. European Journal of Dermatology. 26(5). 477–486. 1 indexed citations
10.
Gonzalez‐McQuire, Sebastian, Kwee Yong, Alain Flinois, et al.. (2016). Retrospective Chart Review Study to Evaluate Health Care Resource Utilization in Patients with Symptomatic Multiple Myeloma in Italy. Value in Health. 19(3). A155–A156.
11.
12.
Raab, Marc S., Michèle Cavo, Michel Delforge, et al.. (2016). Multiple myeloma: practice patterns across Europe. British Journal of Haematology. 175(1). 66–76. 77 indexed citations
13.
Yong, Kwee, Michel Delforge, Christoph Driessen, et al.. (2015). MULTIPLE MYELOMA MANAGEMENT: OUTCOMES IN REAL-WORLD PRACTICE. Haematologica. 100. 252–253. 1 indexed citations
14.
Raab, Marc‐Steffen, Michèle Cavo, Michel Delforge, et al.. (2015). MULTIPLE MYELOMA MANAGEMENT: PRACTICE PATTERNS ACROSS EUROPE. Haematologica. 100. 251–252. 3 indexed citations
15.
Lerebours, Florence, et al.. (2015). Satisfaction des patientes traitées par chimiothérapie en hôpital de jour pour un cancer du sein : résultats de l’enquête TemporELLES. Bulletin du Cancer. 102(4). 316–323. 7 indexed citations
16.
Marteau, Florence, et al.. (2014). Epidemiology of Patients with Metastatic Castrate Resistant Prostate Cancer in Europe and Australia. Value in Health. 17(7). A619–A619. 5 indexed citations
17.
Piedbois, Pascal, et al.. (2009). Étude pharmacoépidémiologique sur l'utilisation de fulvestrant en pratique clinique en France. Bulletin du Cancer. 96(6). 695–702.
18.
Pouchot, J., et al.. (2007). Perceptions in 7700 patients with rheumatoid arthritis compared to their families and physicians. Joint Bone Spine. 74(6). 622–626. 29 indexed citations
19.
20.
Serin, D., et al.. (2004). Parcours de femmes 2001. ONCOLOGIE. 6(7). 494–504. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kejal Parikh Breakdown of academic impact, for papers by Per Trøllund Pedersen Breakdown of academic impact, for papers by Jagoda Jasielec Breakdown of academic impact, for papers by S. Verelst Breakdown of academic impact, for papers by Omar Nadeem Breakdown of academic impact, for papers by Alessandra Pompa Breakdown of academic impact, for papers by Shakira J. Grant Breakdown of academic impact, for papers by Ulf Christian Frølund Breakdown of academic impact, for papers by Lisa Sproat Breakdown of academic impact, for papers by Charlene M. McShane
Rankless by CCL
2026